Page last updated: 2024-11-02

piretanide and Cardiac Failure

piretanide has been researched along with Cardiac Failure in 16 studies

piretanide: potent inhibitor of chloride transport; structure

Research Excerpts

ExcerptRelevanceReference
"To evaluate the acute and chronic effects of diuretic monotherapy with 3 mg piretanide bid, 46 patients (pts) with congestive heart failure (NYHA II-III) secondary to coronary artery disease were studied."9.06Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure--a placebo-controlled trial. ( Bauer, U; Cernoch, K; Fehske, KJ; Haerer, W; Hetzel, M; Hombach, V; Mouselimis, N; Stauch, M; Sultan, N, 1990)
"A double-blind parallel group study was carried out to compare the effects of piretanide on daily glucose profiles, symptoms of congestive heart failure and serum electrolytes with those of furosemide in 24 diabetic in-patients suffering from congestive heart failure."9.06The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide. ( Car, N; Skrabalo, Z; Verho, M, 1988)
"The diuretic and clinical efficacy and safety of piretanide, a new high-ceiling loop diuretic, was determined in patients with mild to moderately severe congestive heart failure."9.06Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure. ( Baumgardner, S; Chardo, F; Charuzi, Y; Kim, CS; Liang, CS; Sherman, LG, 1986)
"Piretanide, a diuretic that acts on the loop of Henle, was used to treat patients with cardiac failure."9.05Comparison of piretanide and chlorothiazide in the treatment of cardiac failure. ( Gillies, A; Morgan, T; Myers, J, 1980)
"The effects of piretanide and a hydrochlorothiazide (HCT)-triamterene combination were compared in an open, controlled, randomised study on two groups of 15 patients, aged 42-74 years, with congestive heart failure (NYHA II-III)."9.05[Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene]. ( Gonska, BD; Kreuzer, H, 1985)
"In a randomized double-blind, parallel group study, the effects of piretanide on serum electrolytes and on symptoms of congestive heart failure were compared with those of the combination piretanide plus triamterene in out-patients with mild to severe congestive heart failure."9.05The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure. ( Bückert, C; Freude, J; Jaeger, S; Pahnke, K; Verho, M, 1985)
"1 This study has compared the diuresis produced by a single oral administration of 6 mg piretanide, 9 mg piretanide and 1 mg bumetanide in a group of nine patients with cardiac failure using a balanced randomized design."9.04A single dose comparison of piretanide and bumetanide in congestive cardiac failure. ( Dombey, SL; Homeida, M; Roberts, CJ, 1979)
"The efficacy and pharmacokinetics of the diuretic piretanide were studied in two groups of six patients hospitalized for congestive heart failure."7.67Efficacy and pharmacokinetics of piretanide in patients with congestive heart failure. ( Frey, F; Lahn, W; Marone, C; Rivera, B; Zwahlen, H, 1989)
"Eight patients with chronic heart failure classified as NYHA class II to III (group 1) and nine patients with acute decompensated heart failure classified as NYHA class IV (group 2) were treated with piretanide at a dosage of 12 mg administered intravenously."7.67[Piretanide in chronic and acute decompensated heart failure. Effect on hemodynamics and vasoactive hormones]. ( Hopf, R; Kaltenbach, M; Kirsten, R; Nelson, K; Pooth, R; Sievert, H; Vens-Cappell, F, 1989)
" The renal and metabolic effects of the sulphamoylbenzoic acid diuretic, piretanide, have been studied, under controlled dietary conditions, in 39 patients with congestive cardiac failure."7.67Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure. ( Lant, AF; McNabb, WR; Noormohamed, FH, 1988)
"The haemodynamic effect of a single 12 mg intravenous dose of piretanide was assessed in 11 patients with congestive heart failure."7.66Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure. ( Apoil, E; Hébert, JL; Valette, H, 1983)
"To evaluate the acute and chronic effects of diuretic monotherapy with 3 mg piretanide bid, 46 patients (pts) with congestive heart failure (NYHA II-III) secondary to coronary artery disease were studied."5.06Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure--a placebo-controlled trial. ( Bauer, U; Cernoch, K; Fehske, KJ; Haerer, W; Hetzel, M; Hombach, V; Mouselimis, N; Stauch, M; Sultan, N, 1990)
"A double-blind parallel group study was carried out to compare the effects of piretanide on daily glucose profiles, symptoms of congestive heart failure and serum electrolytes with those of furosemide in 24 diabetic in-patients suffering from congestive heart failure."5.06The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide. ( Car, N; Skrabalo, Z; Verho, M, 1988)
"The diuretic and clinical efficacy and safety of piretanide, a new high-ceiling loop diuretic, was determined in patients with mild to moderately severe congestive heart failure."5.06Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure. ( Baumgardner, S; Chardo, F; Charuzi, Y; Kim, CS; Liang, CS; Sherman, LG, 1986)
"Piretanide, a diuretic that acts on the loop of Henle, was used to treat patients with cardiac failure."5.05Comparison of piretanide and chlorothiazide in the treatment of cardiac failure. ( Gillies, A; Morgan, T; Myers, J, 1980)
"The effects of piretanide and a hydrochlorothiazide (HCT)-triamterene combination were compared in an open, controlled, randomised study on two groups of 15 patients, aged 42-74 years, with congestive heart failure (NYHA II-III)."5.05[Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene]. ( Gonska, BD; Kreuzer, H, 1985)
"In a randomized double-blind, parallel group study, the effects of piretanide on serum electrolytes and on symptoms of congestive heart failure were compared with those of the combination piretanide plus triamterene in out-patients with mild to severe congestive heart failure."5.05The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure. ( Bückert, C; Freude, J; Jaeger, S; Pahnke, K; Verho, M, 1985)
"1 This study has compared the diuresis produced by a single oral administration of 6 mg piretanide, 9 mg piretanide and 1 mg bumetanide in a group of nine patients with cardiac failure using a balanced randomized design."5.04A single dose comparison of piretanide and bumetanide in congestive cardiac failure. ( Dombey, SL; Homeida, M; Roberts, CJ, 1979)
"The efficacy and pharmacokinetics of the diuretic piretanide were studied in two groups of six patients hospitalized for congestive heart failure."3.67Efficacy and pharmacokinetics of piretanide in patients with congestive heart failure. ( Frey, F; Lahn, W; Marone, C; Rivera, B; Zwahlen, H, 1989)
"Eight patients with chronic heart failure classified as NYHA class II to III (group 1) and nine patients with acute decompensated heart failure classified as NYHA class IV (group 2) were treated with piretanide at a dosage of 12 mg administered intravenously."3.67[Piretanide in chronic and acute decompensated heart failure. Effect on hemodynamics and vasoactive hormones]. ( Hopf, R; Kaltenbach, M; Kirsten, R; Nelson, K; Pooth, R; Sievert, H; Vens-Cappell, F, 1989)
" The renal and metabolic effects of the sulphamoylbenzoic acid diuretic, piretanide, have been studied, under controlled dietary conditions, in 39 patients with congestive cardiac failure."3.67Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure. ( Lant, AF; McNabb, WR; Noormohamed, FH, 1988)
"The influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide was investigated in nine patients with congestive heart failure."3.67Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide. ( Hasenfuss, G; Herzog, C; Holubarsch, C; Just, H; Knauf, H; Mutschler, E; Spahn, H, 1987)
"The haemodynamic effect of a single 12 mg intravenous dose of piretanide was assessed in 11 patients with congestive heart failure."3.66Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure. ( Apoil, E; Hébert, JL; Valette, H, 1983)
"Piretanide is a potent 'loop' diuretic whose principal site of action is in the thick ascending limb of the loop of Henle."2.37Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. ( Brogden, RN; Clissold, SP, 1985)

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-199014 (87.50)18.7374
1990's2 (12.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doglio, GR1
Pusajó, JF1
Bonfigli, G1
Hualde, R1
Lafourcade, ES1
Ortiz Maldonado, HG1
Schöpp, W1
Valette, H1
Hébert, JL1
Apoil, E1
Gillies, A1
Morgan, T1
Myers, J1
Silke, B1
Homeida, M1
Roberts, CJ1
Dombey, SL1
Haerer, W1
Bauer, U1
Sultan, N1
Cernoch, K1
Mouselimis, N1
Fehske, KJ1
Hetzel, M1
Stauch, M1
Hombach, V1
Marone, C1
Rivera, B1
Zwahlen, H1
Lahn, W1
Frey, F1
Sievert, H1
Hopf, R1
Vens-Cappell, F1
Kirsten, R1
Nelson, K1
Pooth, R1
Kaltenbach, M1
McNabb, WR1
Noormohamed, FH1
Lant, AF1
Car, N1
Skrabalo, Z1
Verho, M2
Sherman, LG1
Liang, CS1
Baumgardner, S1
Charuzi, Y1
Chardo, F1
Kim, CS1
Hasenfuss, G1
Holubarsch, C1
Herzog, C1
Knauf, H1
Spahn, H1
Mutschler, E1
Just, H1
Clissold, SP1
Brogden, RN1
Gonska, BD1
Kreuzer, H1
Bückert, C1
Freude, J1
Jaeger, S1
Pahnke, K1

Reviews

2 reviews available for piretanide and Cardiac Failure

ArticleYear
Central hemodynamic effects of diuretic therapy in chronic heart failure.
    Cardiovascular drugs and therapy, 1993, Volume: 7 Suppl 1

    Topics: Bumetanide; Cardiac Output; Diuresis; Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans; Mu

1993
Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Drugs, 1985, Volume: 29, Issue:6

    Topics: Angina Pectoris; Animals; Blood Glucose; Diuretics; Dogs; Edema; Heart Failure; Humans; Hypertension

1985

Trials

7 trials available for piretanide and Cardiac Failure

ArticleYear
Comparison of piretanide and chlorothiazide in the treatment of cardiac failure.
    The Medical journal of Australia, 1980, Feb-23, Volume: 1, Issue:4

    Topics: Adult; Aged; Body Weight; Chlorothiazide; Clinical Trials as Topic; Diuretics; Heart Failure; Humans

1980
A single dose comparison of piretanide and bumetanide in congestive cardiac failure.
    British journal of clinical pharmacology, 1979, Volume: 8, Issue:2

    Topics: Aged; Bumetanide; Calcium; Clinical Trials as Topic; Diuretics; Female; Heart Failure; Humans; Male;

1979
Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure--a placebo-controlled trial.
    Cardiovascular drugs and therapy, 1990, Volume: 4, Issue:2

    Topics: Adult; Aged; Catheterization, Swan-Ganz; Diuretics; Echocardiography; Exercise Test; Female; Heart F

1990
The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide.
    Current medical research and opinion, 1988, Volume: 11, Issue:2

    Topics: Adult; Aged; Blood Chemical Analysis; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diur

1988
Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure.
    Clinical pharmacology and therapeutics, 1986, Volume: 40, Issue:5

    Topics: Adult; Aged; Clinical Trials as Topic; Diuresis; Diuretics; Double-Blind Method; Female; Heart Failu

1986
[Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene].
    Deutsche medizinische Wochenschrift (1946), 1985, Nov-22, Volume: 110, Issue:47

    Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Drug Combinations; Female

1985
The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure.
    Pharmatherapeutica, 1985, Volume: 4, Issue:5

    Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Diuretics; Double-Blind Method;

1985

Other Studies

7 other studies available for piretanide and Cardiac Failure

ArticleYear
[Effect of a loop diuretic, piretanide, in severe cardiac insufficiency].
    Medicina, 1984, Volume: 44, Issue:1

    Topics: Diuresis; Diuretics; Female; Heart Failure; Hemodynamics; Humans; Male; Potassium; Sodium; Sulfonami

1984
[Chronic cardiac insufficiency. Treatment with a vasoactive diuretic. Effectiveness and tolerance of piretanide (Arelix mite)].
    ZFA. Zeitschrift fur Allgemeinmedizin, 1983, Nov-10, Volume: 59, Issue:31

    Topics: Adult; Aged; Diuretics; Female; Heart Failure; Humans; Male; Middle Aged; Sulfonamides

1983
Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure.
    European journal of clinical pharmacology, 1983, Volume: 24, Issue:2

    Topics: Adult; Aged; Blood Pressure; Blood Volume; Diuretics; Electrolytes; Female; Heart Failure; Hemodynam

1983
Efficacy and pharmacokinetics of piretanide in patients with congestive heart failure.
    European journal of clinical investigation, 1989, Volume: 19, Issue:4

    Topics: Aged; Aged, 80 and over; Diuresis; Diuretics; Female; Heart Failure; Humans; Kidney; Male; Middle Ag

1989
[Piretanide in chronic and acute decompensated heart failure. Effect on hemodynamics and vasoactive hormones].
    Medizinische Klinik (Munich, Germany : 1983), 1989, Jun-15, Volume: 84, Issue:6

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Catecholamines; Dinoprostone; Diuretics; Female; Heart Fa

1989
Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.
    British journal of clinical pharmacology, 1988, Volume: 26, Issue:2

    Topics: Adult; Aged; Diuretics; Electrolytes; Female; Furosemide; Heart Failure; Humans; Kidney; Male; Middl

1988
Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide.
    Clinical cardiology, 1987, Volume: 10, Issue:2

    Topics: Adult; Aged; Chronic Disease; Diuresis; Diuretics; Edema; Female; Heart Failure; Hemodynamics; Human

1987